JP6298054B2 - 心不全の診断 - Google Patents

心不全の診断 Download PDF

Info

Publication number
JP6298054B2
JP6298054B2 JP2015525897A JP2015525897A JP6298054B2 JP 6298054 B2 JP6298054 B2 JP 6298054B2 JP 2015525897 A JP2015525897 A JP 2015525897A JP 2015525897 A JP2015525897 A JP 2015525897A JP 6298054 B2 JP6298054 B2 JP 6298054B2
Authority
JP
Japan
Prior art keywords
igfbp2
heart failure
patients
concentration
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015525897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015528562A5 (cg-RX-API-DMAC7.html
JP2015528562A (ja
Inventor
ルエ，フィリップ
スミー−ルエ，ファティマ
デムーラン，フランク
ガリニエ，ミシェル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Hospitalier Universitaire de Toulouse
Original Assignee
Centre Hospitalier Universitaire de Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Hospitalier Universitaire de Toulouse filed Critical Centre Hospitalier Universitaire de Toulouse
Publication of JP2015528562A publication Critical patent/JP2015528562A/ja
Publication of JP2015528562A5 publication Critical patent/JP2015528562A5/ja
Application granted granted Critical
Publication of JP6298054B2 publication Critical patent/JP6298054B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4745—Insulin-like growth factor binding protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44704—Details; Accessories
    • G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/4473—Arrangements for investigating the separated zones, e.g. localising zones by electric means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Paper (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • External Artificial Organs (AREA)
JP2015525897A 2012-08-09 2013-08-09 心不全の診断 Expired - Fee Related JP6298054B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305988.3 2012-08-09
EP12305988 2012-08-09
PCT/EP2013/066697 WO2014023820A1 (en) 2012-08-09 2013-08-09 Diagnostic of heart failure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018029702A Division JP6595641B2 (ja) 2012-08-09 2018-02-22 心不全の診断

Publications (3)

Publication Number Publication Date
JP2015528562A JP2015528562A (ja) 2015-09-28
JP2015528562A5 JP2015528562A5 (cg-RX-API-DMAC7.html) 2016-09-15
JP6298054B2 true JP6298054B2 (ja) 2018-03-20

Family

ID=48953397

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015525897A Expired - Fee Related JP6298054B2 (ja) 2012-08-09 2013-08-09 心不全の診断
JP2018029702A Active JP6595641B2 (ja) 2012-08-09 2018-02-22 心不全の診断

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018029702A Active JP6595641B2 (ja) 2012-08-09 2018-02-22 心不全の診断

Country Status (16)

Country Link
US (2) US20150219669A1 (cg-RX-API-DMAC7.html)
EP (1) EP2883057B1 (cg-RX-API-DMAC7.html)
JP (2) JP6298054B2 (cg-RX-API-DMAC7.html)
CY (1) CY1121406T1 (cg-RX-API-DMAC7.html)
DK (1) DK2883057T3 (cg-RX-API-DMAC7.html)
ES (1) ES2713098T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20190341T1 (cg-RX-API-DMAC7.html)
HU (1) HUE042708T2 (cg-RX-API-DMAC7.html)
LT (1) LT2883057T (cg-RX-API-DMAC7.html)
PL (1) PL2883057T3 (cg-RX-API-DMAC7.html)
PT (1) PT2883057T (cg-RX-API-DMAC7.html)
RS (1) RS58553B1 (cg-RX-API-DMAC7.html)
SI (1) SI2883057T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201900108T1 (cg-RX-API-DMAC7.html)
TR (1) TR201902555T4 (cg-RX-API-DMAC7.html)
WO (1) WO2014023820A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3004891T3 (pl) * 2013-06-06 2019-09-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarker ponownej hospitalizacji po niewydolności serca
JP7401442B2 (ja) * 2018-01-31 2023-12-19 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規使用
US20220390468A1 (en) * 2019-11-06 2022-12-08 National University Corporation Kagawa University Heart failure marker
CN120053474B (zh) * 2025-02-26 2025-12-12 浙江大学 辅酶a在制备心肌细胞铁死亡抑制剂中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183681A1 (en) * 2005-02-14 2006-08-17 Bio-Rad Laboratories, Inc. Stabilized compositions containing natriuretic peptides
JP4465469B2 (ja) * 2005-02-21 2010-05-19 国立大学法人佐賀大学 循環器病マーカーとしてのインターロイキン１３
EP1722232A1 (en) 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
US20080166734A1 (en) * 2005-12-21 2008-07-10 David Xing-Fei Deng Genes and methods of using the same for diagnosis and for targeting the therapy of cardiovascular disease
US20080112888A1 (en) * 2006-06-30 2008-05-15 Schering Corporation Igfbp2 biomarker
EP2498095A3 (en) 2007-01-25 2012-11-28 Roche Diagniostics GmbH Use of IGFBP-7 in the assessment of heart failure
EP2310860A1 (en) * 2008-07-30 2011-04-20 INSERM - Institut National de la Santé et de la Recherche Médicale Blood glutathione as a biomarker for screening asymptomatic patients at risk for heart failure
US20130345322A1 (en) * 2010-07-14 2013-12-26 Commonwealth Scientific And Industrial Research Organisation Diagnostic for colorectal cancer
JP5676763B2 (ja) * 2010-08-26 2015-02-25 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 動脈性高血圧症から心不全への初期移行の評価におけるバイオマーカーの使用
WO2013163345A1 (en) 2012-04-24 2013-10-31 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
WO2014116708A1 (en) * 2013-01-22 2014-07-31 Singulex, Inc. Endothelin in the diagnosis of cardiac disease

Also Published As

Publication number Publication date
TR201902555T4 (tr) 2019-03-21
US11061037B2 (en) 2021-07-13
RS58553B1 (sr) 2019-05-31
LT2883057T (lt) 2019-04-25
US20150219669A1 (en) 2015-08-06
SI2883057T1 (sl) 2019-07-31
PT2883057T (pt) 2019-03-06
JP6595641B2 (ja) 2019-10-23
CY1121406T1 (el) 2020-05-29
HUE042708T2 (hu) 2019-07-29
EP2883057A1 (en) 2015-06-17
EP2883057B1 (en) 2018-12-05
JP2018109640A (ja) 2018-07-12
JP2015528562A (ja) 2015-09-28
ES2713098T3 (es) 2019-05-17
HRP20190341T1 (hr) 2019-05-31
WO2014023820A1 (en) 2014-02-13
PL2883057T3 (pl) 2019-07-31
SMT201900108T1 (it) 2019-05-10
US20180143208A1 (en) 2018-05-24
DK2883057T3 (en) 2019-03-18

Similar Documents

Publication Publication Date Title
US20190120852A1 (en) Diagnosis of cardiovascular disease
CN109564225B (zh) 作为指示不良事件的标志物的组蛋白和/或proADM
EP3279665B1 (en) Circulating esm-1 (endocan) in the assessment of atrial fibrillation
RU2764766C2 (ru) Гистоны и/или proadm в качестве маркеров, свидетельствующих об органной дисфункции
JP6595641B2 (ja) 心不全の診断
US20110104813A1 (en) Diagnosis of early stage cardiac dysfunction
WO2013153177A1 (en) Prognosis of adverse events in patients with suspected chronic heart failure
JP6768847B2 (ja) 心房細動の再発の予測のための循環アンジオポエチン−２（Ａｎｇ−２）
JP2016525693A (ja) 心不全の評価におけるアルファ−クリスタリンｂ（ｃｒｙａｂ）の使用
US7998690B2 (en) Methods for the detection and monitoring of congestive heart failure
Berry et al. Proteomics analysis reveals IGFBP2 as a candidate diagnostic biomarker for heart failure
CN105102984B (zh) sCD14或它的片段或衍生物用于风险分级、诊断和预后的用途
US20220202828A1 (en) Insulin-like growth factor axis proteins as circulating pulmonary arterial hypertension biomarkers
JP2011523072A (ja) １型糖尿病を有する患者の合併症の評価
CN112888948A (zh) 用于评定Afib相关性脑卒中的CES-2（羧酸酯酶-2）
AU2016201172B2 (en) Diagnosis of cardiovascular disease
Koukoui et al. IJC Metabolic & Endocrine
WO2016113719A1 (en) Use of 1,25-dihydroxyvitamin d values in ratio with pth as a prognostic biomarker
HK1228502A1 (en) Prognosis of cardiovascular disease

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150313

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20160728

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160728

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170428

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170606

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170801

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180123

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180222

R150 Certificate of patent or registration of utility model

Ref document number: 6298054

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees